Literature DB >> 7618549

CT of the liver after cryotherapy of hepatic metastases: imaging findings.

R F McLoughlin1, J F Saliken, G McKinnon, D Wiseman, W Temple.   

Abstract

Cryotherapy is the in situ destruction of abnormal tissue using subzero temperatures (Fig. 1). Recent studies have demonstrated the technical feasibility, safety, and effectiveness of hepatic cryotherapy in the treatment of liver tumors [1, 2]. Such treatment can be precisely focused on the tumor, thereby preserving surrounding normal tissue. In addition, because major vessels with flowing blood are protected from cryoablation, tumors adjacent to these vessels can be treated without sacrificing vasculature. Hepatic cryoablation is therefore particularly suitable for patients who do not qualify for surgical resection because of multiple metastases involving both lobes of the liver, or because of lesions close to major blood vessels. After the procedure, CT during arterioportography is of little value in distinguishing cryolesion from malignant tumor (Fig. 2), and CT with IV contrast enhancement is recommended for follow-up. It is important to distinguish CT findings of successful and unsuccessful treatment, treatment complications such as abscess and cholestasis, and recurrent tumor. The purpose of this essay is to illustrate the findings on CT with IV contrast enhancement in various situations, emphasizing features that are useful in making accurate differential diagnosis.

Entities:  

Mesh:

Year:  1995        PMID: 7618549     DOI: 10.2214/ajr.165.2.7618549

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  5 in total

Review 1.  Cryosurgery in the treatment of liver metastasis from colorectal cancer.

Authors:  T S Ravikumar; R Sotomayor; R Goel
Journal:  J Gastrointest Surg       Date:  1997 Sep-Oct       Impact factor: 3.452

2.  [Cryoablation - back again?].

Authors:  P Isfort; T Penzkofer; A H Mahnken
Journal:  Radiologe       Date:  2012-01       Impact factor: 0.635

Review 3.  Locoregional therapies for hepatocellular carcinoma and the new LI-RADS treatment response algorithm.

Authors:  Ania Kielar; Kathryn J Fowler; Sara Lewis; Vahid Yaghmai; Frank H Miller; Hooman Yarmohammadi; Charles Kim; Victoria Chernyak; Takeshi Yokoo; Jeffrey Meyer; Isabel Newton; Richard K Do
Journal:  Abdom Radiol (NY)       Date:  2018-01

4.  Hepatic radiofrequency under CT-fluoroscopy guidance.

Authors:  D Laganà; G Carrafiello; M Mangini; D Lumia; L Mocciardini; C Chini; G Pinotti; S Cuffari; C Fugazzola
Journal:  Radiol Med       Date:  2008-02-25       Impact factor: 3.469

5.  Histological, CT, and intraoperative ultrasound appearance of hepatic tumors previously treated by laparoscopic radiofrequency ablation.

Authors:  T Mason; E Berber; J C Graybill; A Siperstein
Journal:  J Gastrointest Surg       Date:  2007-07-25       Impact factor: 3.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.